[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@PeptidreamInc Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1879416454778613760.png) @PeptidreamInc PeptiDream Inc.

PeptiDream Inc. posts on X about $4587t, kyoto, fda, $alxn the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1879416454778613760/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1879416454778613760/c:line/m:interactions.svg)

- X Week XXX +57%
- X Month XXX +85%
- X Months XXXXX +66%

### Mentions: X [#](/creator/twitter::1879416454778613760/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1879416454778613760/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XX +200%

### Followers: XX [#](/creator/twitter::1879416454778613760/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1879416454778613760/c:line/m:followers.svg)

- X Week XX no change
- X Month XX +11%
- X Months XX +100%

### CreatorRank: undefined [#](/creator/twitter::1879416454778613760/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1879416454778613760/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[travel destinations](/list/travel-destinations)  XXXX% [stocks](/list/stocks)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$4587t](/topic/$4587t) #1, [kyoto](/topic/kyoto) 9.09%, [fda](/topic/fda) 9.09%, [$alxn](/topic/$alxn) 9.09%, [discovered](/topic/discovered) 9.09%, [$7747t](/topic/$7747t) 9.09%, [$2502t](/topic/$2502t) 9.09%, [$3407t](/topic/$3407t) 9.09%, [japan](/topic/japan) XXXX%

**Top accounts mentioned or mentioned by**
[@citeline](/creator/undefined) [@alexionpharma](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"📢 We will participate in the 65th Annual Meeting of the Japanese Society of Nuclear Medicine (Nov 13-15 Kyoto) PD/PDR will host lectures academic presentations and seminars 👉 Learn more: #NuclearMedicine #Kyoto"  
[X Link](https://x.com/PeptidreamInc/status/1986693011326312820)  2025-11-07T07:11Z XX followers, XXX engagements


"📢We've submitted INDs to the US FDA for Phase X trials of 225Ac-PD-32766 (radiotherapeutic) & 64Cu-PD-32766 (radiodiagnostic) in Clear Cell Renal Cell Carcinoma. Details: #Radiopharmaceuticals #KidneyCancer #CAIX #CA9 #PeptideTherapeutics #Macrocycles"  
[X Link](https://x.com/PeptidreamInc/status/1993219676932129233)  2025-11-25T07:26Z XX followers, XXX engagements


"Excited to share that Alexion AstraZeneca Rare Disease (@AlexionPharma) has started a Phase X trial of ALXN2420 for adults with Acromegaly originally discovered at PeptiDream. Details:"  
[X Link](https://x.com/PeptidreamInc/status/1993974335019864239)  2025-11-27T09:25Z XX followers, XXX engagements


"R&D Day archive & decks are now available. Explore our R&D strategy pipeline updates and milestones. Video: Presentation material:"  
[X Link](https://x.com/PeptidreamInc/status/1998351793382920255)  2025-12-09T11:19Z XX followers, XXX engagements


"We are excited to announce the nomination of a clinical development candidate from our collaboration with Asahi Kasei Pharma We look forward to further progress in the program and the advancement of the candidate into clinical development"  
[X Link](https://x.com/PeptidreamInc/status/1998657013736485092)  2025-12-10T07:32Z XX followers, XX engagements


"We are pleased to announce the approval of a Phase X clinical research for 64Cu-PD-29875 (targeting Claudin 18.2) in gastric cancer patients at the National Cancer Center Japan. jRCT Link: #Radiopharmaceuticals #Radioligandtherapy"  
[X Link](https://x.com/PeptidreamInc/status/1999016984558842240)  2025-12-11T07:22Z XX followers, XX engagements